Share on Facebook
Share on Twitter
Share on LinkedIn

The German drug maker Boehringer Ingelheim has agreed to pay $650 million to settle thousands of lawsuits involving its blood thinner Pradaxa,the company said Wednesday.

The settlement will most likely resolve most of the 4,000 cases in state and federal courts filed by patients and their families who claimed that Boehringer failed to properly warn them that the drug, which is used to prevent blood clots, caused serious and sometimes fatal bleeding that could not easily be reversed. The first case was set to go to trial in September.

Click here to read more.